US_FEDERAL process · buyer country US · award
IMMUNOPROTEOMIC PROFILING OF ANTIBODIES AGAINST EPSTEIN-BARR VIRUS IN GASTRIC CANCER AND PREMALIGNANT LESIONS IN SUPPORT OF HHS, NIH, NCI, DCEG, IIB
Department of Health and Human Services
Not reported
Data last updated Oct 22, 2026 · Source: USAspending.gov
- Buyer identifier
- Not reported
- Primary supplier
- ARIZONA STATE UNIVERSITY
- Procurement method
- Not reported
- Tender deadline
- Not reported
- Contract period
- Not reported — Not reported
- Native value
- Not reported
- USD comparison
- Not shown — no auditable FX observation
- Official source
- Open notice ↗
Description
IMMUNOPROTEOMIC PROFILING OF ANTIBODIES AGAINST EPSTEIN-BARR VIRUS IN GASTRIC CANCER AND PREMALIGNANT LESIONS IN SUPPORT OF HHS, NIH, NCI, DCEG, IIB
Suppliers
- ARIZONA STATE UNIVERSITY · primary
Official lifecycle
Process timeline
- Award announced
IMMUNOPROTEOMIC PROFILING OF ANTIBODIES AGAINST EPSTEIN-BARR VIRUS IN GASTRIC CANCER AND PREMALIGNANT LESIONS IN SUPPORT OF HHS, NIH, NCI, DCEG, IIB
- Value increased
IMMUNOPROTEOMIC PROFILING OF ANTIBODIES AGAINST EPSTEIN-BARR VIRUS IN GASTRIC CANCER AND PREMALIGNANT LESIONS IN SUPPORT OF HHS, NIH, NCI, DCEG, IIB
Auditable model output
Predictive intelligence
Append-only source history
Source records
| Record | Date | Stages | Fetched |
|---|